Avid Bioservices Inc (CDMO)

[sulaco]

Excellent point, EBS; you're right. We must get BP on board

to validate, vindicate, and confirm what we're all convinced of here: Bavi definitely has the potential to the next SOC and a key player in oncological imaging.

SOC in a major cancer involves billions of dollars. Biopharm gets unfairly tagged as a pumper for simply stating this fact.

But it's true. Cancer is ridiculously rampant right now. If your drug performs well in this space, evidence-based medicine will DEMAND that it be used. PPHM's market cap will soar. It is not unreasonable to consider this.

That's why I maintain a strong position in PPHH.

Hey, you pick your horse and let her run.